Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus: A meta-analysis

BACKGROUND: Drug intensification is often required for patients with type 2 diabetes mellitus on stable metformin therapy. Among the potential candidates for a combination therapy, sodium-glucose transporter-2 (SGLT2) inhibitors have shown promising outcomes. This meta-analysis was performed to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Gong, Yanping, Li, Chunlin, Lu, Yanhui, Liu, Yu, Shao, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502143/
https://www.ncbi.nlm.nih.gov/pubmed/28682870
http://dx.doi.org/10.1097/MD.0000000000007201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502143/
https://www.ncbi.nlm.nih.gov/pubmed/28682870
http://dx.doi.org/10.1097/MD.0000000000007201

Ejemplares similares